Esther A. M. Bührman

From consent to participatory governance: The need for multi-stakeholder alignment in iPSC-based drug repurposing.

Induced pluripotent stem cells (iPSCs) are increasingly used as disease models to accelerate drug repurposing, especially for rare diseases. While ethical and regulatory issues in iPSC research have been widely discussed, little is known about how these challenges are addressed in practice. To provide insights into the...